✦ LIBER ✦

Pediatric issues in new therapies for hepatitis B and C

✍ Scribed by Kathleen B. Schwarz

Book ID: 107537974
Publisher: Springer
Year: 2003
Tongue: English
Weight: 383 KB
Volume: 5
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-003-0025-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New therapies for hepatitis C

✍ Apurva A. Modi; Jay H. Hoofnagle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

See Articles on Pages 631 and 640. N o challenge in clinical hepatology is as great today as the management of patients with chronic hepatitis C who have failed to respond to an adequate course of antiviral therapy. At present, the optimal regimen is a combination of peginterferon and ribavirin. 1 W

Novel therapies in hepatitis B and C

✍ Bart Takkenberg; Joep de Bruijne; Christine Weegink; Peter Jansen; Hendrik Reesi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 530 KB

Challenges and successes in developing n

Challenges and successes in developing new therapies for hepatitis C

✍ De Francesco, Raffaele; Migliaccio, Giovanni 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 406 KB

Hepatectomy for hepatitis B-, hepatitis

Hepatectomy for hepatitis B-, hepatitis C-, and dual hepatitis B- and C-related hepatocellular carcinoma in Taiwan

✍ Lee, Wei-Chen ;Jeng, Long-Bin ;Chen, Miin-Fu 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 75 KB

Absence of hepatitis B and C viruses in

Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis

✍ Michael J. Nowicki; Thomas R. Welch; Nafees Ahmad; I. Kenneth Kuramoto; Eleanor 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 336 KB

Does antiviral therapy for hepatitis B a

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

✍ Anna Suk-Fong Lok 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB